Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shizuoka Caffeine Co., Ltd. is a specialized Japanese manufacturer focusing on the production of high-purity caffeine and tea-derived chemical compounds. Founded in 1913, the company is recognized as one of the world's leading suppliers of both natural caffeine, extracted from tea leaves, and synthetic anhydrous caffeine. It operates as a critical supplier of active pharmaceutical ingredients (APIs) for use in analgesics, cold medicines, and respiratory treatments. Following its acquisition by Mitsubishi Chemical Corporation, the company has integrated its manufacturing expertise into a global supply chain serving the pharmaceutical, nutraceutical, and beverage industries. Their facilities maintain rigorous quality standards, including GMP compliance, to ensure suitability for medical and food-grade applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shizuoka Caffeine.